Proton pump inhibitors receiving and prognosis of patients after scheduled percutaneous coronary interventions
The urgency of the study is determined by the lack of data necessary in order to assess the safety of prolonged use of proton pump inhibitors (PPI) in patients with IHD combined with anti-aggregant therapy. The aim of the study was to study the relationship between the use of PPI and the risk of thr...
Main Authors: | A L Komarov, O O Shakhmatova, V Muraseeva, E S Novikova, E V Guskova, E P Panchenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2018-09-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/viewFile/32996/pdf |
Similar Items
-
Effect of food on the pharmacokinetics of omeprazole, pantoprazole and rabeprazole
by: Dolores Ochoa, et al.
Published: (2020-07-01) -
A Retrospective Study to Assess the Effect of Proton Pump Inhibitors on Renal Profile in a South Indian Hospital
by: A. Avinash, et al.
Published: (2017-04-01) -
Proton Pump Inhibitors and Fracture Risk: A Review of Current Evidence and Mechanisms Involved
by: Benjamin Ka Seng Thong, et al.
Published: (2019-05-01) -
Practical considerations in the management of proton-pump inhibitors
by: Lara Aguilera-Castro, et al. -
Proton Pump Inhibitors: How Safe is Long Usage of Pantoprazole?
by: Yu.M. Stepanov, et al.
Published: (2013-09-01)